Pharmaceuticals, Biotechnology and Life Sciences
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. released its Winter 2020 Drug Price Forecast projecting that health systems, including inpatient and non-acute environments,…
Latest approval for apalutamide could benefit a population of more than 100,000 people living with mHSPC across Europe1 BEERSE, Belgium–(BUSINESS…
DUBLIN–(BUSINESS WIRE)–The “Obsessive-Compulsive Disorder – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The latest…
DUBLIN–(BUSINESS WIRE)–The “Diarrhea – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary The latest Pharmaceutical…
DUBLIN–(BUSINESS WIRE)–The “Iron Deficiency Anemia – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Iron Deficiency…
– Submission based on two clinical trials in patients with advanced hepatocellular carcinoma who had received prior systemic therapy –…
JERUSALEM–(BUSINESS WIRE)–OurCrowd, the global crowdfunding venture investing platform and Israel’s leading venture investor, will feature Dr. Ferid Murad, 1998 Nobel…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the…
PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc. an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that…